ALUMIS INC. - 10-Q Filing
Alumis Inc. reports third quarter 2026 financial results and details collaborative revenue arrangements with Kaken Pharmaceutical Co. Ltd.
Tickers: $ALMS
Alumis Inc. reports third quarter 2026 financial results and details collaborative revenue arrangements with Kaken Pharmaceutical Co. Ltd.
Tickers: $ALMS